Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suhuang Cough Capsule in Postinfectious Cough
CTR20191080Phase 4Active
- Sponsor
- Beijing Dongfang Yunjia Technology Development
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of suhuang antitussive capsule in postinfectious cough, cough variant asthma (CVA), sponsored by Beijing Dongfang Yunjia Technology Development. Started May 2019; status: active.
02
Drugs
suhuang antitussive capsule
03
Conditions
postinfectious coughcough variant asthma (CVA)
Beyond the preview
Go deeper on CTR20191080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191080.